can semaglutide cause bone loss Ozempic and Loss: UK Evidence and Bone Health Guidance Weight loss induced bone loss:

[29, 30, 31] Risk factors: Diabetes (especially in combination with SGLT2 inhibitors use) Reduced oral intake and severe GI symptoms Dehydration Presentation: Nausea, vomiting, abdominal pain Anion gap metabolic acidosis Elevated ketones Normal or mildly elevated glucose Key point: EDKA has not been observed in non-diabetic patients in large cohort data

Its unclear at this point if the medication will help treat cardiovascular disease if someone doesnt have those conditions

Fueron asignados aleatoriamente para recibir una dosis oral diaria de orforglipron (12 mg, 24 mg, 36 mg o 45 mg) o un placebo durante 36 semanas

Obesity affects over 650 million adults worldwide and is a major risk factor for chronic conditions such as type 2 diabetes, cardiovascular disease and certain cancers